127 related articles for article (PubMed ID: 28133180)
1. [Combination Chemotherapy Using Oxaliplatin plus S-1 for Well-Advanced Gastric Cancer].
Saito H; Suematsu Y; Yamagishi S; Takahashi M; Nakayama M; Fukabori M; Morita A; Wakabayashi K; Itoh Y
Gan To Kagaku Ryoho; 2016 Nov; 43(12):1933-1935. PubMed ID: 28133180
[TBL] [Abstract][Full Text] [Related]
2. [Clinical Experience of S-1 and Oxaliplatin(SOX)as the First-Line Chemotherapy for Metastatic/Recurrent Gastric Cancer].
Toyokawa T; Tamura T; Shibutani M; Ohira G; Yamazoe S; Kimura K; Nagahara H; Amano R; Tanaka H; Muguruma K; Yashiro M; Hirakawa K; Ohira M
Gan To Kagaku Ryoho; 2017 May; 44(5):405-408. PubMed ID: 28536336
[TBL] [Abstract][Full Text] [Related]
3. A randomized phase II trial of S-1-oxaliplatin versus capecitabine-oxaliplatin in advanced gastric cancer.
Kim GM; Jeung HC; Rha SY; Kim HS; Jung I; Nam BH; Lee KH; Chung HC
Eur J Cancer; 2012 Mar; 48(4):518-26. PubMed ID: 22243774
[TBL] [Abstract][Full Text] [Related]
4. [A safety analysis in patients treated with oxaliplatin plus S-1 as adjuvant therapy for gastric cancer].
Zhou Y; Huang J; Yang L; Chi Y; Qu T; Lü X; Wang JW
Zhonghua Zhong Liu Za Zhi; 2012 Nov; 34(11):860-4. PubMed ID: 23291138
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of the efficacy and safety of capecitabine or tegafur, gimeracil and oteracil potassium capsules combined with oxaliplatin chemotherapy regimens in the treatment of advanced gastric cancer].
Wan Y; Hui H; Wang X; Wu J; Sun S
Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):28-34. PubMed ID: 26796803
[TBL] [Abstract][Full Text] [Related]
6. [Highly Advanced Gastric Cancer Leading to Immediate Perforation on Day Three of Chemotherapy with S-1 plus Oxaliplatin].
Neduka H; Munemoto M; Ojima T; Earashi M; Fujii H; Nonomura A
Gan To Kagaku Ryoho; 2016 Nov; 43(12):1939-1941. PubMed ID: 28133182
[TBL] [Abstract][Full Text] [Related]
7. Docetexal plus S-1 versus oxaliplatin plus S-1 for first-line treatment of patients with advanced gastric cancer: a retrospective study.
Wang M; Wu M; Wang W; Wang Q; Wang Y
Oncol Res Treat; 2014; 37(1-2):24-8. PubMed ID: 24613905
[TBL] [Abstract][Full Text] [Related]
8. [Combination chemotherapy using docetaxel, cisplatin, and S-1 for far advanced gastric cancer].
Hamakawa T; Kurokawa Y; Takiguchi S; Takahashi T; Yamasaki M; Miyata H; Nakajima K; Mori M; Dok Y
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2342-4. PubMed ID: 22202376
[TBL] [Abstract][Full Text] [Related]
9. S-1 plus leucovorin versus S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin in patients with advanced gastric cancer: a randomised, multicentre, open-label, phase 2 trial.
Hironaka S; Sugimoto N; Yamaguchi K; Moriwaki T; Komatsu Y; Nishina T; Tsuji A; Nakajima TE; Gotoh M; Machida N; Bando H; Esaki T; Emi Y; Sekikawa T; Matsumoto S; Takeuchi M; Boku N; Baba H; Hyodo I
Lancet Oncol; 2016 Jan; 17(1):99-108. PubMed ID: 26640036
[TBL] [Abstract][Full Text] [Related]
10. [A Case of Pathological Complete Response after SOX Chemotherapy in Advanced Gastric Cancer].
Mori K; Kishi K; Masuzawa T; Tsukada R; Tanemura M; Tei M; Suzuki Y; Otsuka M; Furukawa K; Akamatsu H
Gan To Kagaku Ryoho; 2016 Nov; 43(12):2234-2236. PubMed ID: 28133280
[TBL] [Abstract][Full Text] [Related]
11. [Study of S-1 and oxaliplatin(SOX) plus bevacizumab as first-line therapy in patients with unresectable colorectal cancer].
Maruo H; Suzuki K; Ishikawa S; Murakami T; Higashi Y; Shoji T; Yamazaki M; Taniguchi M; Nishiyama R
Gan To Kagaku Ryoho; 2014 Dec; 41(13):2583-6. PubMed ID: 25596052
[TBL] [Abstract][Full Text] [Related]
12. Combination Chemotherapy with S-1 and Oxaliplatin (SOX) as First-Line Treatment in Elderly Patients with Advanced Gastric Cancer.
Zhong DT; Wu RP; Wang XL; Huang XB; Lin MX; Lan YQ; Chen Q
Pathol Oncol Res; 2015 Sep; 21(4):867-73. PubMed ID: 25648439
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of a triplet regimen of S-1 combined with irinotecan and oxaliplatin in patients with metastatic gastric cancer: clinical and pharmacogenetic results.
Park SR; Kong SY; Rhee J; Park YI; Ryu KW; Lee JH; Kim YW; Choi IJ; Kim CG; Lee JY; Cho SJ; Kim NK
Ann Oncol; 2011 Apr; 22(4):890-896. PubMed ID: 20860988
[TBL] [Abstract][Full Text] [Related]
14. Phase I clinical and pharmacokinetic/pharmacogenetic study of a triplet regimen of S-1/irinotecan/oxaliplatin in patients with metastatic colorectal or gastric cancer.
Park SR; Hong YS; Lim HS; Seong MW; Kong SY; Kim SY; Park YI; Jung KH
Cancer Chemother Pharmacol; 2013 Nov; 72(5):953-64. PubMed ID: 23982118
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel/oxaliplatin/fluorouracil (TOF) regimen versus S-1/oxaliplatin (SOX) regimen for metastatic gastric cancer patients.
Dai X; Zhang X; Wang C; Jiang J; Wu C
Oncotarget; 2017 May; 8(18):30495-30501. PubMed ID: 27911869
[TBL] [Abstract][Full Text] [Related]
16. Phase I study of neoadjuvant chemoradiotherapy with S-1 and oxaliplatin in patients with locally advanced gastric cancer.
Lee DJ; Sohn TS; Lim DH; Ahn HK; Park SH; Lee J; Park JO; Park YS; Lim HY; Choi DI; Kim KM; Choi MG; Noh JH; Bae JM; Kim S; Min BH; Kang WK
Cancer Chemother Pharmacol; 2012 May; 69(5):1333-8. PubMed ID: 22311161
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of oxaliplatin plus S-1 as first-line treatment for advanced gastric cancer (G-SOX study).
Koizumi W; Takiuchi H; Yamada Y; Boku N; Fuse N; Muro K; Komatsu Y; Tsuburaya A
Ann Oncol; 2010 May; 21(5):1001-5. PubMed ID: 19875759
[TBL] [Abstract][Full Text] [Related]
18. [A Case of Rhabdomyolysis Related to SOX Therapy for Liver Metastasis of Gastric Cancer].
Sato K; Akiyama H; Kogure Y; Suwa Y; Momiyama M; Ishibe A; Endo I
Gan To Kagaku Ryoho; 2017 Apr; 44(4):329-331. PubMed ID: 28428515
[TBL] [Abstract][Full Text] [Related]
19. Study protocol of a phase II clinical trial (KSCC1501A) examining oxaliplatin + S-1 for treatment of HER2-negative advanced/recurrent gastric cancer previously untreated with chemotherapy.
Saeki H; Emi Y; Oki E; Tokunaga S; Kakeji Y; Akagi Y; Baba H; Baba E; Maehara Y;
BMC Cancer; 2018 Jan; 18(1):57. PubMed ID: 29310611
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of neoadjuvant S-1 and oxaliplatin followed by surgery for resectable advanced gastric adenocarcinoma.
Honma Y; Yamada Y; Terazawa T; Takashima A; Iwasa S; Kato K; Hamaguchi T; Shimada Y; Ohashi M; Morita S; Fukagawa T; Machida N; Katai H
Surg Today; 2016 Sep; 46(9):1076-82. PubMed ID: 26563224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
